FRAXE mutation in a mentally retarded subject and in his phenotypically normal twin brother.
The FRAXE fragile site, 600 kb distal to the more common FRAXA, has been reported to be expressed in subjects with mild non-syndromal mental retardation (MR). Amplification of more than 200 GCC repeats, associated with methylation of the adjacent CpG island at Xq28, leads to the expression of the fragile site. In 1996 a large gene, FMR2, transcribed distally from the CpG island and downregulated by repeat expansion and methylation, was identified. Among 232 mentally retarded patients, tested FRAXA negative, we identified an Italian family segregating a hypermethylated expansion at the FRAXE locus in two dizygotic twin brothers, their sister and their mother. The index case was referred at 23 years of age with severe MR, epilepsy, a dysmorphic face with a high arched palate, marfanoid habitus and hyperreflexia of the lower limbs. His brother was referred to as normal and psychometric tests confirmed he is not mentally retarded. All members of the family underwent FRAXE molecular analysis, after cytogenetic expression of the fraX site and negative FRAXA test. Interestingly, an expansion and a hypermethylation at the FRAXE locus were found in all of them. Fibroblasts from the clinically normal brother were assayed for FMR2 expression and the transcription of the gene was found to be silenced. The presence of a phenotypically normal male with absent FMR2 expression in fibroblasts suggests that the relationship between the FRAXE mutation, FMR2 expression and MR needs to be further investigated.
Lo Nigro
C
C
Laboratory of Human Genetics, Galliera Hospital, Genoa, Italy.
Faravelli
F
F
Cavani
S
S
Perroni
L
L
Novello
P
P
Vitali
M
M
Bricarelli
F D
FD
Grasso
M
M
D000328:Adult; D018899:CpG Islands / Q000235:genetics; D019175:DNA Methylation; D005600:Fragile X Syndrome / Q000235:genetics*; D005817:Genetic Counseling; D006801:Humans; D008607:Intellectual Disability / Q000235:genetics*; D008297:Male; D009154:Mutation; D009687:Nuclear Proteins; D010641:Phenotype; D011506:Proteins / Q000235:genetics*; D015534:Trans-Activators
C099930:AFF2 protein, human; D009687:Nuclear Proteins; D011506:Proteins; D015534:Trans-Activators